Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid-associated orbitopathy developed during hormone replacement therapy.

C G Øgard1, C Øgard, T P Almdal

  • 1Department of Endocrinology and Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark.

Acta Ophthalmologica Scandinavica
|July 17, 2001
PubMed
Summary

Hormone replacement therapy with estrogen and progesterone may trigger thyroid-associated orbitopathy (TAO) in postmenopausal women. Discontinuation of these hormones resolved TAO symptoms, suggesting a potential causal link.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Data on the use of dietary supplements in Danish patients with type 1 and type 2 diabetes.

Data in brief·2018
Same author

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Glycaemic threshold for diabetes-specific retinopathy among individuals from Saudi Arabia, Algeria and Portugal.

Diabetes research and clinical practice·2014
Same author

Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

Reproducibility of ultrasonography for assessing abdominal fat distribution in a population at high risk of diabetes.

Nutrition & diabetes·2013

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Hormone Therapy

Background:

  • Thyroid-associated orbitopathy (TAO) is an autoimmune condition affecting the eye socket.
  • The role of exogenous hormones in TAO pathogenesis is not well-established.
  • Estrogen and progesterone are commonly used in hormone replacement therapy (HRT).

Observation:

  • A 56-year-old postmenopausal woman developed TAO symptoms during estrogen/progesterone therapy.
  • Eye symptoms resolved upon HRT withdrawal and recurred upon re-initiation.
  • The patient had no prior history of thyroid or autoimmune diseases.

Findings:

  • Estrogen and/or progesterone therapy appears to be linked to the development of TAO.
  • Hormone replacement therapy may induce or exacerbate TAO in susceptible individuals.

Related Experiment Videos

  • This case highlights a potential novel trigger for TAO.

    • Implications:

    • Estrogen and progesterone may play a pathogenetic role in TAO.
    • Clinicians should consider HRT when evaluating TAO in postmenopausal women.
    • Further research is warranted to elucidate the mechanisms linking HRT and TAO.